Historically good results with IL-4 inhibitors raise questions with U.S. audience ...

Ethics committees and funding agencies often receive protocols that involve either too many or too few animals to answer the specific research question being investigated. It is evident that a greater ...

Like it or not, big companies are getting trounced by smaller teams. Find out why indie gems are stealing the spotlight from mainstream releases.

While Google Chrome is the most popular internet browser, it's probably not the best to use. These are important reasons you ...

Hello, and welcome to Wave Life Sciences Positive Interim Phase I Clinical Data from INLIGHT Trial of WVE-007 for Obesity Call. [Operator Instructions] Also, as a reminder, this conference is being ...

Role-playing games as we know them wouldn't be the same today if these ambitious creations hadn't dared to go where no one else would.

BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...

A new wave of device code phishing shows how threat actors are scaling account compromise using AI and end‑to‑end automation.

Security tech is a mess of broken readers and glitchy updates; the fix isn't more "innovation," but making sure your ...

Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can ...

ADC Therapeutics (NYSE:ADCT) executives used a recent fireside chat at the H.C. Wainwright conference to outline the ...

WAVE Life Sciences (NASDAQ:WVE) highlighted positive interim data from the ongoing Phase 1 INLIGHT trial of WVE-007, a GalNAc ...